FORTUNE Small Business Ranks America's Fastest-Growing Small Companies
CINCINNATI--(BUSINESS WIRE)--June 26, 2006--FORTUNE Small Business announced today that Meridian Bioscience, Inc. (NASDAQ:VIVO) has been ranked 66 on the sixth annual FSB 100 list of the fastest growing small companies in America. The list, which is comprised of public companies, appears in the July/August issue of FORTUNE Small Business and is available at FSB.com.
John A. Kraeutler, President and Chief Operating Officer, stated, "We would like to thank FORTUNE Small Business for recognizing Meridian Bioscience. This achievement is a tribute to our dedicated employees and our loyal customers around the world. We will strive to continue to develop clinically significant diagnostic and therapeutic tools that improve the delivery of superior healthcare and, that consistently deliver optimal shareholder value."
California tops the list of the states with the most companies on the FORTUNE Small Business 100 with 18 companies, followed by Texas with 12, New York with eight and New Jersey with seven.
To compile the sixth annual list, FORTUNE Small Business asked financial research firm Zacks to rank public companies with revenues less than $200 million and a stock price of more than $1, based on their percentage growth in earnings, revenue, and stock performance over the past three years. Banks and real estate firms were excluded.
Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these diagnostic products and tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections. Meridian diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents, specialty biologicals and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products and technologies to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers and biotech companies in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.
CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700
SOURCE: Meridian Bioscience, Inc.